La catena delle opzioni mostra i dati chiave delle opzioni azionarie di MAIA Biotechnology a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per MAIA Biotechnology..

MAIA Biotechnology (AMEX:MAIA) Azioni, Catena delle Opzioni

MAIA Biotechnology

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

MAIA Biotechnology Inc

News

CLVT

Clarivate's IPfolio To Drive Daikin's IP Innovation And Operational Efficiency

<h3>Companies Reporting Before The Bell</h3>
• Codere Online Luxembourg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDRO#NASDAQ">CDRO</a>) is projected to report quarterly earnings at $0.01 per share on revenue of $49.81 million. 
• CollPlant Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLGN#NASDAQ">CLGN</a>) is likely to report quarterly loss at $0.37 per share on revenue of $730 thousand. 
• QuantaSing Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSG#NASDAQ">QSG</a>) is likely to report quarterly earnings at $0.27 per share on revenue of $134.60 million. 
• Frontline (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRO#NYSE">FRO</a>) is projected to report quarterly earnings at $0.45 per share on revenue of $361.42 million. 
• Golden Ocean Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOGL#NASDAQ">GOGL</a>) is likely to report quarterly earnings at $0.33 per share on revenue of $196.25 million. 
• 111 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YI#NASDAQ">YI</a>) is expected to report earnings for its third quarter. 
• Arbe Robotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBE#NASDAQ">ARBE</a>) is likely to report quarterly loss at $0.11 per share on revenue of $450 thousand. 
• X Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYF#NYSE">XYF</a>) is likely to report earnings for its third quarter. 
• BOS Better Online Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOSC#NASDAQ">BOSC</a>) is expected to report earnings for its third quarter. 
<h3>Companies Reporting After The Bell</h3>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

ARBE

BOSC

CDRO

CLGN

GOGL

Earnings Scheduled For November 27, 2024

MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) has become the epicenter of intense market speculation following a dramatic 23.64% stock decline over the past five sessions, while Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) <a href="https://www.benzinga.com/24/11/42206056/bitcoin-ethereum-dogecoin-tumble-as-diamond-hands-lock-in-gains-analyst-anticipates-strong-buyback-pressure-to-follow-sell-pressure">experienced a 5.52% drop during the same period</a>.
What Happened: Prominent investment analyst Gary Black of The Future Fund LLC raised alarm bells about MicroStrategy&#8217;s valuation, arguing that the company&#8217;s stock price &#8220;makes no sense.&#8221; Black&#8217;s analysis suggests the stock should be valued at around $105 per share—approximately 75% lower than its current trading price.
&#8220;Don't say I didn't warn you,&#8221; Black wrote. 
The company, led by CEO Michael Saylor, currently holds 386,700 Bitcoin, valued at $35.4 billion. With a market capitalization of $81.5 billion, MicroStrategy continues to trade at roughly 2.3 times the current value of its Bitcoin holdings.
The Kobeissi Letter highlighted unprecedented retail investor activity, noting that on a single Wednesday last week, retail investors purchased approximately $42 million of MSTR stock. 
This marked the largest daily retail purchase on record, with total retail investment approaching $100 million for the week. The stock experienced extraordinary trading dynamics, with last week seeing $136 billion in trading volume—exceeding even Amazon Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), despite AMZN having a market cap nearly 29 times larger.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Don't say I didn't warn you. Certainly got a lot of hate mail when we posted this 4 days ago. <a href="https://twitter.com/search?q=%24MSTR&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$MSTR</a> <a href="https://t.co/OwQlDbGstv">https://t.co/OwQlDbGstv</a> <a href="https://t.co/DNPMdBBtLY">https://t.co/DNPMdBBtLY</a>
&mdash; Gary Black (@garyblack00) <a href="https://twitter.com/garyblack00/status/1861661628019687856?ref_src=twsrc%5Etfw">November 27, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42207866/bitcoin-as-a-strategic-reserve-asset-cardano-founder-charles-hoskinson-predicts-btc-will-surge-to-500k-amid-defi-boom">Bitcoin Could Surge To $500K Amid DeFi Boom, Trump&#8217;s Pledge To Establish A BTC Strategic Reserve, Says Cardano Founder Charles Hoskinson</a>
Why It Matters: Standard Chartered analyst Geoffrey Kendrick provided critical market insights, suggesting Bitcoin may test support zones between $85,000 and $88,700. His year-end price target remains $125,000, with a long-term <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42192364/bitcoin-correction-could-go-as-deep-as-88700-but-125000-year-end-target-remains-in-play-says-standard-chartered">projection of $200,000 by the end of 2025</a>.
MicroStrategy&#8217;s investment approach involves a cyclical strategy of borrowing money through convertible notes, purchasing Bitcoin, driving price appreciation, selling shares at a premium, and reinvesting in more Bitcoin. 
Analysts are questioning the sustainability of this model, particularly whether Saylor can continue raising debt to purchase Bitcoin and if institutional and retail investor enthusiasm will persist.
Bitcoin&#8217;s recent pullback from near $100,000 to around $93,440 reflects broader market uncertainties, including reduced U.S. Treasury term premiums, <a href="https://www.benzinga.com/24/11/42206056/bitcoin-ethereum-dogecoin-tumble-as-diamond-hands-lock-in-gains-analyst-anticipates-strong-buyback-pressure-to-follow-sell-pressure">upcoming options expirations, and institutional repositioning</a>.
Price Action: Bitcoin was trading at $93,433 at the time of writing, up by 0.80% in the last 24 hours.
According to <a href="https://www.benzinga.com/quote/MSTR/analyst-ratings">Benzinga Pro data</a>, the consensus price target for MicroStrategy is $449.50. The highest price target is $690, while the lowest is $140, implying a potential 54.56% upside based on the most recent analyst ratings.
<figure class="wp-block-image size-large"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27025122/Screenshot-2024-11-27-at-1.19.55%E2%80%AFPM-1024x373.png" alt="" class="wp-image-666817" /></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42206056/bitcoin-ethereum-dogecoin-tumble-as-diamond-hands-lock-in-gains-analyst-anticipates-strong-buyback-pressure-to-follow-sell-pressure">Bitcoin, Ethereum, Dogecoin Tumble As &#8216;Diamond Hands&#8217; Lock In Gains: Top Analyst Anticipates BTC Rebound</a></li>
</ul>
Image Via Shutetsrtock 
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Kaustubh-Bagalkote" target="_blank" rel="noreferrer noopener">Kaustubh Bagalkote</a>

Analyst Color

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$BTC

AMZN

MSTR

Michael Saylor's MicroStrategy Plunges 23% In 5 Sessions While Bitcoin Slips Under 6%: Gary Black Quips 'Don't Say I Didn't Warn You'

<ul>
<li>Fast Track designation indicates LBS-007's potential in filling the unmet medical need of acute leukemia</li>
<li>LBS-007 is the Company's investigational medicinal product for the treatment of acute leukemia</li>
<li>A Phase 1/2 trial in patients with relapsed or resistant acute leukemias is ongoing</li>
<li>LBS-007, the Company's lead asset, has been granted orphan drug designations for acute myeloid leukemia and acute lymphocytic leukemia by the U.S. FDA</li>
</ul>

BLTE

Lin BioScience's LBS-007 Granted FDA Fast Track Designation For Acute Leukemia Breakthrough

Russian-linked hacking group RomCom has exploited vulnerabilities in Mozilla Firefox and Microsoft Corp.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) Windows to target users across Europe and North America.
What Happened: In a blog post on Monday, security researchers at ESET shared that they have discovered that RomCom used two previously unknown zero-day vulnerabilities in a widespread cyberattack.
These flaws allowed hackers to deploy a "zero-click" exploit, installing malware remotely without user interaction.
See Also: <a href="https://www.benzinga.com/24/11/42153854/apples-future-ventures-huaweis-new-chip-and-googles-antitrust-woes-this-week-in-appleverse?itm_source=parsely-api">Apple&#8217;s Future Ventures, Huawei&#8217;s New Chip, And Google&#8217;s Antitrust Woes: This Week In Appleverse</a>
RomCom leveraged these vulnerabilities through malicious websites to infect victims' devices with backdoor malware, granting them extensive access.
Mozilla patched the Firefox vulnerability on Oct. 9, while Microsoft addressed the Windows flaw on Nov. 12, after a report from Google&#8217;s Threat Analysis Group.
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
Why It Matters: RomCom was previously associated with a ransomware attack on Japanese tech giant Casio. The group is also notorious for targeting organizations allied with Ukraine. 
The attack by RomCom is also part of a broader pattern of Russian-linked cyber activities targeting various sectors globally. In September, it was reported that <a href="https://www.benzinga.com/news/24/09/40848363/pro-russian-hackers-reportedly-disrupt-taiwan-stock-exchange-on-thursday-services-restored-in-22-min">pro-Russian hackers</a> disrupted the Taiwan Stock Exchange, causing temporary service instability.
During the same month, <a href="https://www.benzinga.com/news/24/09/40912191/harris-walz-campaign-targeted-by-russian-hackers-microsoft-threat-analysis-center-notices-shift-in-t">Microsoft&#8217;s Threat Analysis Center</a> reported a shift in Russian cyber tactics, with operations targeting the Kamala Harris–Tim Walz campaign ahead of the 2024 presidential election.
Previously in March, Microsoft revealed that Russian hackers, known as Nobelium, stole some of its source code by <a href="https://www.benzinga.com/markets/equities/24/03/37561005/microsoft-says-russian-hackers-stole-code-after-spying-on-top-executives-attack-still-ongoing">spying on senior executives</a>.
Check out more of Benzinga's Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42155932/apple-black-friday-2024-get-up-to-200-in-gift-cards-on-iphones-macs-airpods-and-more-heres-everything-you-need-to-know?itm_source=parsely-api">Apple&#8217;s 2024 Black Friday Deals: Gift Cards Over Discounts — Here&#8217;s What You&#8217;ll Get</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Tech

MSFT

Russian Hackers Launch Widespread Cyber Assault Using Firefox And Windows Zero-Days: What You Need To Know About The RomCom Exploit

The rise in prices of cryptocurrencies like Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>), and others may have enabled lower-income households to take out new mortgages to purchase property, a new study revealed.
What Happened: A paper by the U.S. Treasury&#8217;s Office of Financial Research has <a href="https://www.financialresearch.gov/briefs/files/OFRBrief-24-08-crypto-exposure-and-household-financial-outcomes.pdf">identified </a>a correlation between the surge in cryptocurrency investments and an increase in debt, particularly mortgages, in areas with high exposure to cryptocurrencies. 
Data showed that for low-income households in high-crypto exposure zip codes, the mortgage holder rate nearly quadrupled from 4.1% in January 2020 to 15.4% in January 2024. Additionally, the average balance per mortgage increased by over 150% from $171,773 in 2020 to $443,123.
&#8220;This indicates that low-income households may be using cryptocurrency gains to take out new mortgages and take out larger mortgages,&#8221; the study said.
The study also found that the average income of the cohort was $40,664 in January 2024, indicating a mortgage debt-to-income ratio of 0.53, well above the recommended benchmark of 0.36.
&#8220;It is particularly concerning because higher debt-to-income ratios are positively correlated with future default rates, especially during periods of turmoil such as the 2008 financial crisis,&#8221; the study stated.
That said, higher leverage among these groups hasn&#8217;t resulted in higher delinquency rates as of Q1 2024. On the contrary, delinquency on debt dropped the most among low-income households.
Mortgage delinquency dropped by 4.2% among low-income households in high-crypto exposure areas compared to 3.8% in low-crypto areas.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42205579/jim-cramer-says-bitcoin-and-ethereum-deserve-a-spot-in-your-portfolio-as-hedge-against-rising-us-debt-ive-liked-crypto-for-a-very-long-time">Jim Cramer Says Bitcoin And Ethereum &#8216;Deserve A Spot In Your Portfolio&#8217; As Hedge Against Rising US Debt: &#8216;I&#8217;ve Liked Crypto For A Very Long Time&#8217;</a>
It&#8217;s worth noting that during the period between January 2020 and January 2024, the total cryptocurrency market capitalization increased by 737%, from roughly $197 billion to $1.65 trillion.
Additionally, major coins like Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) have leaped 355%, more than fourfold, in the said time period.
An August report <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40837412/65-of-u-s-consumers-think-crypto-could-replace-cash-in-the-future-deutsche-bank-report-fin">disclosed </a>that U.S. consumers are becoming more&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39253573/crypto-adoption-is-coming-slow-and-steady-research-report-says" target="_blank" rel="noreferrer noopener">receptive to cryptocurrency</a>, with fewer than 1% now dismissing it as a "fad," a significant drop from previous years.
Enthusiasts have placed high hopes in President-elect Donald Trump, who enthusiastically supported cryptocurrencies during his election campaign and is speculated to create the <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42098407/donald-trump-reportedly-eyeing-the-first-crypto-focused-role-in-the-white-house">first-ever White House role dedicated to cryptocurrency policy</a>.
Price Action: At the time of writing, Bitcoin was trading at $93,246.09, up 0.77% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/government/regulations/24/11/42206456/trump-administration-to-reportedly-let-cftc-regulate-bitcoin-ethereum-spot-market-is-the-sec-set-to-lose-its-grip-over-crypto">Trump Administration To Reportedly Let CFTC Regulate Bitcoin, Ethereum Spot Market, Is The SEC Set To Lose Its Grip Over Crypto?</a></li>
</ul>
Image generated using Dall-E

$DOGE

Surge In Bitcoin, Dogecoin And Other Cryptos Boosting Home Ownership Among Low-Income Americans, Says Treasury Department

LEDS

SemiLEDs Q4 EPS $(0.08) Up From $(0.18) YoY, Sales $1.32M Down From $1.45M YoY

HAFN

Hafnia Ltd Reported Q3 EPS of $0.42 Vs $0.33 Est

Hafnia Ltd Reported Q3 Revenue Of $497.9M Vs $365.67M Est

Cardano (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ada/usd">ADA</a>) founder Charles Hoskinson, a co-founder of Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), predicted Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) could surge to between $250,000 and $500,000 within the next 12 to 24 months, citing growing institutional investment and <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42198909/trump-linked-crypto-platform-world-liberty-financial-appoints-justin-sun-as-advisor-after-30-million-investment">emerging decentralized finance opportunities</a>.
What Happened: In a recent <a href="https://www.youtube.com/watch?v=1qh7PlT2tq4">livestream</a> from Colorado, Hoskinson emphasized Bitcoin&#8217;s transformative potential, describing it as more than just a cryptocurrency but a strategic asset for governments and institutions worldwide. 
Hoskinson has deep roots in the cryptocurrency ecosystem and highlighted Bitcoin&#8217;s evolution from a &#8220;dormant project&#8221; to a potentially revolutionary financial technology.
The cryptocurrency veteran believes Bitcoin&#8217;s ecosystem could experience unprecedented growth, particularly with the development of DeFi layers that could dramatically expand its utility. 
He stated that &#8220;governments are considering Bitcoin as a strategic reserve asset,&#8221; drawing a parallel to gold&#8217;s historical role as a store of value. Hoskinson predicted that &#8220;Bitcoin-based DeFi will surpass all other ecosystems within 24 to 36 months.&#8221;
In a keynote speech at a Bitcoin conference in Nashville, Tennessee, this past July, President-elect Donald Trump pledged to establish the United States as the &#8220;crypto capital of the planet&#8221; and indicated plans to create a Bitcoin strategic reserve utilizing the <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41770352/bitcoins-future-under-president-elect-donald-trump-a-look-at-his-crypto-policies">cryptocurrency held by the government</a>.
See Also: <a href="https://www.benzinga.com/24/11/42206614/polygons-pol-token-outshines-bitcoin-ethereum-in-30-day-gains-top-analyst-anticipates-no-major-selling-pressure-in-days-ahead">Crypto&#8217;s Next Mega-Rocket? Analyst Forecasts Insane 2725%-6600% Surge For This Coin</a>
Why It Matters: The prediction comes amid a volatile cryptocurrency landscape. Recent data shows Bitcoin experiencing significant price fluctuations, with long-term holders offloading 728,000 coins in the past 30 days—the l<a href="https://www.benzinga.com/24/11/42206056/bitcoin-ethereum-dogecoin-tumble-as-diamond-hands-lock-in-gains-analyst-anticipates-strong-buyback-pressure-to-follow-sell-pressure">argest sell-off since April</a>. 
Despite short-term volatility, market analysts remain cautiously optimistic. Haider Rafique, Global Chief Marketing Officer at OKX exchange, noted the significant profit potential for investors, with the <a href="https://www.benzinga.com/24/11/42206056/bitcoin-ethereum-dogecoin-tumble-as-diamond-hands-lock-in-gains-analyst-anticipates-strong-buyback-pressure-to-follow-sell-pressure">average holding price around $30,000</a>.
While bullish on Bitcoin, Hoskinson remains committed to Cardano&#8217;s role in the broader cryptocurrency ecosystem. He positioned Cardano as a &#8220;spiritual successor to Bitcoin&#8221; and emphasized the importance of creating hybrid applications that integrate Bitcoin functionality, showcasing his continued innovation in the blockchain space.
Price Action: Bitcoin the leading cryptocurrency by market capitalization, is currently trading at $93,201.11. The price has risen by 1.74% over the past 24 hours and 0.63% over the last seven days, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42198180/dogecoin-gets-its-first-exchange-traded-product-in-sweden">Dogecoin Gets Its First Exchange-Traded Product In Sweden</a></li>
</ul>
Image via Pexels
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

$ADA

$ETH

Bitcoin Could Surge To $500K Amid DeFi Boom, Trump's Pledge To Establish A BTC Strategic Reserve, Says Cardano Founder Charles Hoskinson

Investors who supported Elon Musk&#8216;s acquisition of Twitter are reportedly seeing significant returns due to the rising valuation of his AI company, xAI. These investors, who received a 25% stake in xAI, are poised for substantial gains.
What Happened: xAI, founded by Musk last year, is reportedly nearing the completion of a $5 billion fundraising round. This could potentially double its valuation to $50 billion within six months, offsetting some of the unrealized losses from the Twitter deal. Notable beneficiaries include Fidelity, Oracle co-founder Larry Ellison, Saudi Prince Alwaleed bin Talal, and Jack Dorsey.
The strategic intertwining of Musk&#8217;s ventures, including Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and SpaceX, underscores the benefits for those backing his enterprises. The latest funding round will bring xAI&#8217;s total investment to approximately $11 billion, crucial for its AI model development and supercomputer infrastructure, the Financial Times <a href="https://www.ft.com/content/5c9ca1f6-b6fe-4c96-84e2-38e3eee90f3b">reported</a> on Wednesday.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42152684/musk-tweet-sparks-dogecoin-surge-fuels-speculation-on-x-payments?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Musk Tweet Sparks Dogecoin Surge, Fuels Speculation On X Payments</a>
Despite Twitter&#8217;s declining value, xAI&#8217;s growth has been advantageous for Musk&#8217;s backers, who initially contributed $7.1 billion for the Twitter takeover. The Financial Times noted that only previous xAI investors could participate in the latest fundraising, maintaining their stake undiluted.
xAI is yet to respond to Benzinga&#8217;s queries.
Why It Matters: The rise in xAI&#8217;s valuation comes as the company seeks to raise <a href="https://www.benzinga.com/24/11/42022077/elon-musks-xai-seeks-6b-at-50b-valuation-to-acquire-100k-nvidia-chips-for-memphis-data-center">up to $6 billion </a>to acquire 100,000 Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) chips for its Memphis data center. This move is part of xAI&#8217;s strategy to bolster its AI capabilities and infrastructure.
Additionally,&nbsp;Cathie Wood&#8216;s ARK Venture Fund&nbsp;has <a href="https://www.benzinga.com/markets/24/11/42180383/want-to-invest-in-spacex-and-xai-cathie-woods-ark-venture-fund-brings-musks-private-companies-to-your-portfolio">opened up investment opportunities</a> in Musk&#8217;s private ventures, including xAI, SpaceX, and the rebranded social media platform X. The&nbsp;ARK Venture Fund&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKVX#NASDAQ">ARKVX</a>) would give exposure to the companies, with xAI representing 1.5%&nbsp;of the portfolio.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/tech/24/11/42183055/elon-musk-slams-californias-proposal-to-shut-tesla-evs-out-of-consumer-rebates-in-state-this-is-insane?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Slams California&#8217;s Proposal To Shut Tesla EVs Out Of Consumer Rebates In State: &#8216;This Is Insane&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Photo via Shutterstock

General

ARKVX

NVDA

TSLA

Jack Dorsey, Larry Ellison Among Elon Musk's Twitter Backers Set To Gain Windfall From xAI Deal

Frontline (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRO#NYSE">FRO</a>) reported quarterly earnings of $0.34 per share which missed the analyst consensus estimate of $0.45 by 24.44 percent. This is a 5.56 percent decrease over earnings of $0.36 per share from the same period last year. The company reported quarterly sales of $490.36 million which beat the analyst consensus estimate of $361.42 million by 35.68 percent. This is a 30.04 percent increase over sales of $377.08 million the same period last year.

Frontline Q3 Adj. EPS $0.34 Misses $0.45 Estimate, Sales $490.36M Beat $361.42M Estimate

Arbe Robotics Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBE#NASDAQ">ARBE</a>) will release earnings results for its third quarter, before the opening bell on Wednesday, Nov. 27.
Analysts expect the Tel Aviv-Yafo, Israel-based bank to report a quarterly loss at 11 cents per share, versus a year-ago loss of 10 cents per share. Arbe Robotics projects to report revenue of $450 thousand for the recent quarter, compared to $479 thousand a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Nov. 4, Arbe Robotics announced the closing of up to $49 million public offering.
Arbe Robotics shares fell 1% to close at $1.91 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/TCOM/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/599ecad3ca17380001263601/suji-desilva">Roth MKM analyst Suji Desilva</a> maintained a Buy rating and cut the price target from $4 to $2 on March 8. This analyst has an accuracy rate of 75%.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58d5296ab85e930001416e5c/gary-mobley">Wells Fargo analyst Gary Mobley</a> maintained an Overweight rating and slashed the price target from $5 to $4 on March 8. This analyst has an accuracy rate of 71%.</li>
</ul>
Considering buying ARBE stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="554" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27021944/image-285-1024x554.png" alt="" class="wp-image-666760" style="width:660px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27021944/image-285-1024x554.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27021944/image-285-300x162.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27021944/image-285-768x415.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27021944/image-285.png 1171w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/42188912/jim-cramer-linde-is-a-terrific-company-sees-another-stock-up-75-as-not-done">Jim Cramer: Linde Is A &#8216;Terrific&#8217; Company, Sees Another Stock Up 75% As &#8216;Not Done&#8217;</a></li>
</ul>

Price Target

Pre-Market Outlook

Analyst Ratings

Trading Ideas

Top Wall Street Forecasters Revamp Arbe Robotics Price Expectations Ahead Of Q3 Earnings

The CNN Money Fear and Greed index showed a slight improvement in the overall market sentiment, while the index remained in the &#8220;Greed&#8221; zone on Tuesday.
U.S. stocks settled higher on Tuesday, with the Dow Jones index and S&amp;P 500 surging to fresh record levels during the session.
Dick&#8217;s Sporting Goods Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) reported upbeat earnings for its third quarter. Kohl's Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) reported worse-than-expected third-quarter results, cut its FY24 EPS guidance, and projected a net sales decrease of 7%-8%. Best Buy Co., Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) reported weaker-than-expected earnings for its fiscal 2025 third quarter.
On the economic data front, the S&amp;P CoreLogic Case-Shiller home price index rose 4.6% year-over-year in September versus a 5.2% increase in August. Sales of new single-family homes in the U.S. dipped by 17.3% to an annualized rate of 610,000 in October.
Most sectors on the S&amp;P 500 closed on a positive note, with utilities, communication services, and consumer discretionary stocks recording the biggest gains on Tuesday. However, energy and materials stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by around 124 points to 44,860.31 on Tuesday. The S&amp;P 500 rose 0.57% to 6,021.63, while the Nasdaq Composite rose 0.63% to close at 19,175.58 during Tuesday's session.
Investors are awaiting earnings results from Frontline plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRO#NYSE">FRO</a>) and Golden Ocean Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOGL#NASDAQ">GOGL</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 64.4, the index remained in the &#8220;Greed&#8221; zone on Tuesday, versus a prior reading of 64.2.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/42188912/jim-cramer-linde-is-a-terrific-company-sees-another-stock-up-75-as-not-done">Jim Cramer: Linde Is A &#8216;Terrific&#8217; Company, Sees Another Stock Up 75% As &#8216;Not Done&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Long Ideas

Dow, S&P 500 Settle At Record Highs, Best Buy Reports Weaker Than Expected Earnings: Fear Index Remains In 'Greed' Zone

Frontline plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRO#NYSE">FRO</a>) will release earnings results for the third quarter, before the <a href="https://www.benzinga.com/quote/FRO/earnings">opening bell on Wednesday, Nov. 27</a>.
Analysts expect Frontline to report quarterly earnings at 38 cents per share. That's up from 36 cents per share a year ago. The Limassol, Cyprus-based company projects to report quarterly revenue of $317.59 million, compared to $232.03 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Aug. 30, Frontline reported better-than-expected second-quarter sales results.
Frontline shares fell 5% to close at $18.07 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/TJX/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Jefferies analyst Omar Nokta maintained a Buy rating and cut the price target from $30 to $26 on Nov. 14. This analyst has an accuracy rate of 70%.</li>
<li>BTIG analyst Gregory Lewis upgraded the stock from Neutral to Buy with a price target of $30 on Oct. 7. This analyst has an accuracy rate of 76%.</li>
<li>Evercore ISI Group analyst Jonathan Chappell maintained an Outperform rating and cut the price target from $33 to $32 on July 23. This analyst has an accuracy rate of 70%.</li>
<li>JP Morgan analyst Samuel Bland maintained a Neutral rating and cut the price target from $23 to $22.3 on March 1. This analyst has an accuracy rate of 72%.</li>
<li>Deutsche Bank analyst Amit Mehrotra upgraded the stock from Hold to Buy with a price target of $26 on Jan. 9. This analyst has an accuracy rate of 72%.</li>
</ul>
Considering buying FRO stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="583" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27021136/image-284-1024x583.png" alt="" class="wp-image-666749" style="width:667px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27021136/image-284-1024x583.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27021136/image-284-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27021136/image-284-768x437.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27021136/image-284.png 1073w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/42188912/jim-cramer-linde-is-a-terrific-company-sees-another-stock-up-75-as-not-done">Jim Cramer: Linde Is A &#8216;Terrific&#8217; Company, Sees Another Stock Up 75% As &#8216;Not Done&#8217;</a></li>
</ul>

Frontline Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Golden Ocean Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOGL#NASDAQ">GOGL</a>) reported quarterly earnings of $0.28 per share which missed the analyst consensus estimate of $0.33 by 15.15 percent. This is a 100 percent increase over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $260.621 million which beat the analyst consensus estimate of $195.750 million by 33.14 percent. This is a 17.58 percent increase over sales of $221.663 million the same period last year.

Earnings Beats

Earnings Misses

Golden Ocean Group Q3 2024 GAAP EPS $0.28 Misses $0.33 Estimate, Sales $260.621M Beat $195.750M Estimate

With U.S. stock futures trading mixed this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Frontline Plc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRO#NYSE">FRO</a>) to report quarterly earnings at 45 cents per share on revenue of $361.42 million before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Frontline shares rose 1.1% to $18.26 in after-hours trading.</li>
<li>HP Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) reported in-line earnings for its fourth quarter, while sales topped estimates. HP said it expects first-quarter adjusted earnings of between 70 cents and 76 cents per share, versus the 85 cent estimate, and fiscal 2025 earnings of between $3.45 and $3.75 per share, versus the $3.60 estimate. HP shares fell 7.4% to $36.19 in the after-hours trading session.</li>
<li>Analysts are expecting Golden Ocean Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOGL#NASDAQ">GOGL</a>) to post quarterly earnings at 32 cents per share on revenue of $195.75 million. The company will release earnings before the markets open. Golden Ocean shares gained 0.4% to $10.90 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) reported better-than-expected earnings for its third quarter, while sales missed estimates. The company reported quarterly earnings of $2.15 per share, which beat the analyst consensus estimate of $2.05. Quarterly revenue came in at $24.37 billion, which missed the consensus estimate of $24.65 billion and is an increase over revenue of $22.25 billion from the same period last year. Dell shares tumbled 11.3% to $125.75 in the after-hours trading session.</li>
<li>CrowdStrike Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) posted upbeat results for its third quarter. The company said it expects fourth-quarter revenue to be between $1.029 billion and $1.035 billion versus estimates of $1.03 billion. The company anticipates fourth-quarter adjusted earnings of 84 cents to 86 cents per share versus estimates of 86 cents per share. CrowdStrike shares fell 5.7% to $343.38 in the after-hours trading session.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/42188912/jim-cramer-linde-is-a-terrific-company-sees-another-stock-up-75-as-not-done">Jim Cramer: Linde Is A &#8216;Terrific&#8217; Company, Sees Another Stock Up 75% As &#8216;Not Done&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

CRWD

DELL

HP, CrowdStrike And 3 Stocks To Watch Heading Into Wednesday

The shares of common stock are expected to begin trading on the NYSE American under ticker symbol "VENU" on November 27, 2024. The offering is expected to close on November 29, 2024, subject to customary closing conditions.
The Company intends to use the net proceeds from the offering to fund the expansion of its business operations, further development of Company services, business promotion activities, and for working capital and general corporate purposes, including general market expansion and due diligence efforts to explore the opening of new restaurant, entertainment, and music venues.

IPOs

VENU

Reported Earlier, Venu Holding Prices $12M Initial Public Offering Of 1.2M At $10/Share

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fmaximus.com%2F&amp;esheet=54158762&amp;newsitemid=20241126626604&amp;lan=en-US&amp;anchor=Maximus&amp;index=1&amp;md5=26f28e5ecebffe14bcf89e1d5a14ed8b">Maximus</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>) is pleased to announce that the U.S. Department of Health and Human Services, Centers for Medicare &amp; Medicaid Services (CMS) has withdrawn their early re-procurement of the Contact Center Operations (CCO) 1-800-MEDICARE and Federal Marketplace contract. The early re-procurement of the contract would have otherwise caused Maximus to recompete for the same scope of work it currently performs under its contract today. The current contract retains its available option periods until 2031.

Reported Earlier, Maximus Retains Key CMS Contract, Securing Contact Center Operations Through 2031

The shares are expected to begin trading on the NYSE American under the ticker symbol "BRIA" on November 27, 2024. The Offering is expected to close on November 29, 2024, subject to customary closing conditions.

BRIA

Reported Earlier, BrilliA Prices $10M Initial Public Offering Of 2.5M Class A Common Share At $4/Share

ASTS, ALLO and CMCM are among premarket gainers

MAIA Biotechnology, Inc. (MAIA) has shared an update. MAIA Biotechnology, Inc. has announced promising results from its Phase 2 THIO-101 clinical t...

MAIA Biotechnology Unveils Promising THIO-101 Trial Results

Recent Run-Up Provides MAIA Biotechnology With Breathing Room

MAIA Biotechnology, Inc. (MAIA) has issued an announcement. MAIA Biotechnology, Inc. recently updated investors with a presentation and summary on ...

MAIA Biotechnology Highlights Clinical Progress and Investor Insights

An announcement from MAIA Biotechnology, Inc. (MAIA) is now available. MAIA Biotechnology, Inc. has announced significant year-to-date achievements...

MAIA Biotechnology Reports Progress in Cancer Drug Development

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
MAIA Biotechnology (NYSEMKT:<a href="https://investorplace.com/stock-quotes/maia-stock-quote/">MAIA</a>) just reported results for the second quarter of 2024.<ul><li>MAIA Biotechnology reported earnings per share of -40 cents. This was below the analyst estimate for EPS of -39 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/maia-stock-earnings-maia-biotechnology-for-q2-of-2024/">MAIA Stock Earnings: MAIA Biotechnology Misses EPS for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

MAIA Stock Earnings: MAIA Biotechnology Misses EPS for Q2 2024

MAIA Biotechnology, Inc. ( ($MAIA) ) has shared an announcement. MAIA Biotechnology, Inc. is actively engaging with the financial community, presen...

MAIA Biotechnology Advances with Clinical Trials and Partnerships

In a report released today, Robert LeBoyer from Noble Financial reiterated a Buy rating on MAIA Biotechnology, Inc. (MAIA – Research Report), with ...

Noble Financial Reaffirms Their Buy Rating on MAIA Biotechnology, Inc. (MAIA)

MAIA Biotechnology prices $2.44M private placement

MAIA Biotechnology, Inc. ( ($MAIA) ) has provided an update. MAIA Biotechnology has unveiled promising new data from its Phase 2 trial of THIO comb...

MAIA Biotechnology Reveals Promising Phase 2 Trial Results

AGBA

ALLO

ASTS

BCAN

CMCM

EDBL

MAIA

MNDR

SILO

Screenshot 2024-09-10 at 8.49.39 PM

Biotech

REGN

MAIA Biotechnology&#39;s Phase 2 Study Of THIO In Non-Small Cell Lung Cancer Shows Positive Interim Survival Benefits

Screenshot 2024-06-06 at 5.43.20 PM

New Clinical Data Reveals MAIA Biotechnology&#39;s THIO Achieves High Efficacy In Advanced Non-Small Cell Lung Cancer Treatment

Screenshot 2024-05-21 at 5.35.44 PM

MAIA Biotechnology&#39;s Unique Telomere Targeting Agent Currently In Clinical Development Shows Promise For The Multi-Billion Dollar Cancer Therapy Market

Screenshot 2024-02-28 at 6.41.05 PM

MAIA Biotech Completes Enrollment For Phase 2 Trial Of Its Candidate THIO To Fight Non-Small Cell Lung Cancer

Press Releases

MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA's Approval of a Telomerase Inhibitor Agent Therapy

FDA move illuminates key role of telomere targeting as a viable therapeutic strategy for cancer treatment

MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent

MAIA Biotechnology to Present New Phase 2 Clinical Trial Data at the H.C. Wainwright 26th Annual Global Investment Conference

MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer

MAIA Biotechnology's Phase 2 Study Of THIO In Non-Small Cell Lung Cancer Shows Positive Interim Survival Benefits

MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics

MAIA Biotechnology Announces $2.44 Million Private Placement

MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

Comments

MAIA Biotechnology

MAIA Biotechnology (MAIA) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO